Elisa Kieback is the founder of T-knife. T-knife has raised $383M in total funding. Latest round: Series F. Backed by RA Capital, Fidelity, Janus Henderson.
Dr. Elisa Kieback is the founder and CEO of T-knife, a clinical-stage biotech company focused on developing T-cell receptor therapies for solid tumors. T-knife originated as a spin-off from the Max Delbrück Center (MDC) and Charité in Berlin. Kieback has successfully secured significant funding rounds to advance the company's research and development.
Full founder directory · Investor directory · Company funding database · Fundraising library